Marin-Garcia J, Goldenthal M J, Pierpont E M, Ananthakrishnan R, Perez-Atayde A
The Molecular Cardiology Institute, Highland Park, New Jersey 08904, USA.
Cardiovasc Pathol. 1999 Jul-Aug;8(4):217-22. doi: 10.1016/s1054-8807(99)00010-1.
While mitochondrial abnormalities are increasingly recognized in cardiac diseases including hypertrophic cardiomyopathy, their presence in idiopathic dilated cardiomyopathy and the role that age plays in their incidence and severity have yet not been assessed. Levels of cardiac respiratory enzyme activities and mitochondrial DNA (mtDNA) were examined in 55 subjects with idiopathic dilated cardiomyopathy divided into 3 age groups. Respiratory enzyme activity levels were significantly lower in 37 patients (67%) compared to age-matched controls and increased activity levels were noted in 9 (16%). Decreased activities were found in complex I (n = 11), III (n = 16), IV (n = 12) and V (n = 13), but not in II, the only respiratory complex entirely nuclear-encoded. No age-specific differences were found in the overall frequency of enzymatic abnormalities. However, older patients had significantly increased multiple enzyme activity defects as well as increases in abundance and frequency of the 7.4 kb deletion. In addition, 3 patients were noted with marked reduction in mtDNA levels. None of the pathogenic mtDNA mutations previously associated with hypertrophic cardiomyopathy were found, nor was there any relationship that could be established between levels of specific mtDNA deletions and enzyme activities. In summary, specific mitochondrial abnormalities are heterogenous and frequent in both adults and children with idiopathic dilated cardiomyopathy. Older patients are more likely to have mtDNA deletions and multiple enzyme activity defects. The molecular basis for these abnormalities remains undefined.
虽然线粒体异常在包括肥厚型心肌病在内的心脏疾病中越来越受到认可,但它们在特发性扩张型心肌病中的存在以及年龄在其发生率和严重程度中所起的作用尚未得到评估。对55例特发性扩张型心肌病患者进行了分组,分为3个年龄组,检测了心脏呼吸酶活性水平和线粒体DNA(mtDNA)。与年龄匹配的对照组相比,37例患者(67%)的呼吸酶活性水平显著降低,9例患者(16%)的活性水平升高。在复合体I(n = 11)、III(n = 16)、IV(n = 12)和V(n = 13)中发现活性降低,但在复合体II中未发现,复合体II是唯一完全由核编码的呼吸复合体。在酶异常的总体频率上未发现年龄特异性差异。然而,老年患者的多种酶活性缺陷显著增加,同时7.4 kb缺失的丰度和频率也增加。此外,有3例患者的mtDNA水平显著降低。未发现先前与肥厚型心肌病相关的致病性mtDNA突变,也未发现特定mtDNA缺失水平与酶活性之间存在任何关联。总之,在特发性扩张型心肌病的成人和儿童中,特定的线粒体异常是异质性的且很常见。老年患者更有可能出现mtDNA缺失和多种酶活性缺陷。这些异常的分子基础仍不明确。